131 related articles for article (PubMed ID: 9667282)
1. Long-term pamidronate in multiple myeloma.
Seymour JF
J Clin Oncol; 1998 Jul; 16(7):2572-3. PubMed ID: 9667282
[No Abstract] [Full Text] [Related]
2. [The efficacy of pamidronate in reducing skeletal associated events in patients with advanced multiple myeloma].
Adamietz IA
Strahlenther Onkol; 1997 Jan; 173(1):52-3. PubMed ID: 9082587
[No Abstract] [Full Text] [Related]
3. Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.
Berenson JR; Lichtenstein A; Porter L; Dimopoulos MA; Bordoni R; George S; Lipton A; Keller A; Ballester O; Kovacs M; Blacklock H; Bell R; Simeone JF; Reitsma DJ; Heffernan M; Seaman J; Knight RD
J Clin Oncol; 1998 Feb; 16(2):593-602. PubMed ID: 9469347
[TBL] [Abstract][Full Text] [Related]
4. Pamidronate for the prevention of skeletal-related events in multiple myeloma. What does the public think it is worth?
Dranitsaris G
Int J Technol Assess Health Care; 1999; 15(1):108-22. PubMed ID: 10407599
[TBL] [Abstract][Full Text] [Related]
5. [Strength training and tai-chi to prevent accidental falls].
MMW Fortschr Med; 2007 Nov; 149(45):14, 16. PubMed ID: 18062004
[No Abstract] [Full Text] [Related]
6. Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient.
Kunin M; Kopolovic J; Avigdor A; Holtzman EJ
Nephrol Dial Transplant; 2004 Mar; 19(3):723-6. PubMed ID: 14767032
[No Abstract] [Full Text] [Related]
7. Pamidronate reduces skeletal events but does not improve progression-free survival in early-stage untreated myeloma: results of a randomized trial.
Musto P; Falcone A; Sanpaolo G; Bodenizza C; Cascavilla N; Melillo L; Scalzulli PR; Dell'Olio M; La Sala A; Mantuano S; Nobile M; Carella AM
Leuk Lymphoma; 2003 Sep; 44(9):1545-8. PubMed ID: 14565658
[TBL] [Abstract][Full Text] [Related]
8. Pamidronate for early-stage, untreated myeloma.
Musto P; Falcone A; Sanpaolo G; Bodenizza C; Carella AM
J Clin Oncol; 2003 Aug; 21(16):3177-8; author reply 3178. PubMed ID: 12915612
[No Abstract] [Full Text] [Related]
9. Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
Grasko JM; Herrmann RP; Vasikaran SD
J Oral Maxillofac Surg; 2009 Mar; 67(3):645-9. PubMed ID: 19231794
[No Abstract] [Full Text] [Related]
10. Pamidronate disodium reduces skeletal complications of multiple myeloma.
Oncology (Williston Park); 1996 Feb; 10(2):253. PubMed ID: 8838269
[No Abstract] [Full Text] [Related]
11. [Minodronic acid- its clinical efficacy and prospects for once-a-month dosing regimen].
Hagino H
Clin Calcium; 2011 Jan; 21(1):71-6. PubMed ID: 21187597
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of myeloma disease].
Verevkin IN
Med Sestra; 1981 Nov; 40(11):5-7. PubMed ID: 6915349
[No Abstract] [Full Text] [Related]
13. Fragile bones in a young male.
Hasan U; Rasool H
South Med J; 2006 Oct; 99(10):1143-4. PubMed ID: 17100041
[No Abstract] [Full Text] [Related]
14. Osteoporosis at presentation of childhood ALL: management with pamidronate.
Goldbloom EB; Cummings EA; Yhap M
Pediatr Hematol Oncol; 2005; 22(7):543-50. PubMed ID: 16166046
[TBL] [Abstract][Full Text] [Related]
15. Questions regarding MR imaging appearances of vertebral fractures in multiple myeloma.
Miaux Y; Dion E; Genant HK
Radiology; 1998 Feb; 206(2):563-5. PubMed ID: 9457215
[No Abstract] [Full Text] [Related]
16. Kyphoplasty as a treatment for vertebral compression fractures as a result of multiple myeloma.
Coen D
Clin J Oncol Nurs; 2003; 7(2):236-7. PubMed ID: 12696225
[No Abstract] [Full Text] [Related]
17. [Bone lesion in multiple myeloma].
Ise M; Takagi T
Nihon Rinsho; 2007 Dec; 65(12):2224-8. PubMed ID: 18069264
[TBL] [Abstract][Full Text] [Related]
18. [Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review].
Jotterand V; Moll S; Martin PY; Saudan P
Nephrol Ther; 2009 Apr; 5(2):134-8. PubMed ID: 19013118
[TBL] [Abstract][Full Text] [Related]
19. Myeloma--the therapeutic challenge.
Berenson JR
Med Klin (Munich); 2000 Oct; 95 Suppl 2():19-21. PubMed ID: 11089383
[TBL] [Abstract][Full Text] [Related]
20. Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma.
Henk HJ; Teitelbaum A; Perez JR; Kaura S
Am J Hematol; 2012 May; 87(5):490-5. PubMed ID: 22454220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
